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Oct-2, a POU homeo domain transcription factor, is believed to stimulate B-cell-restricted expression of 
immunoglobulin genes through binding sites in immunoglobulin gene promoters and enhancers. To determine 
whether Oct-2 is required for B-cell development or function, or has other developmental roles, the gene was 
disrupted by homologous recombination. Oct -2  - / -  mice develop normally but die within hours of birth for 
undetermined reasons. Mutants contain normal numbers of B-cell precursors but are somewhat deficient in 
IgM + B cells. These B cells have a marked defect in their capacity to secrete immunoglobulin upon mitogenic 
stimulation in vitro. Thus, Oct-2 is not required for the generation of immunoglobulin-bearing B cells but is 
crucial for their maturation to immunoglobulin-secreting cells and for another undetermined organismal 
function. 
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The differentiation of B-lymphoid cells comprises two 
distinct phases (see Rolink and Melchers 1991). The first 
phase is antigen independent and includes a number of 
interdependent gene activation and rearrangement steps 
that assemble functional immunoglobulin heavy- and 
light-chain genes (see Alt et al. 1986). It ends with the 
generation of surface IgM-bearing virgin B cells. The sec- 
ond phase is antigen dependent and requires external, 
generally T-cell-derived signals to trigger a differentia- 
tion cascade that produces the mature immunoglobulin- 
secreting plasma cell. Control of the transcriptional c- 
tivity of individual immunoglobulin gene loci is central 
to the regulation of this differentiation process and ulti- 
mately determines the functional capacity of the mature 
B cell. 
The expression of immunoglobulin genes in B cells 
requires the interaction of many transcriptional regula- 
tors with their cognate binding sites in the promoters 
and enhancers of the immunoglobulin loci (see Calame 
1989; Staudt and Lenardo 1991). One of these factors is 
Oct-2, a founding member of the POU family of tran- 
scription factors (Herr et al. 1988). Oct-2 binds to the 
octamer motif [consensus sequence, ATGCAAATI by 
conserved POU-specific and POU homeo domains lClerc 
et al. 1988; Ko et al. 1988; Scheidereit et al. 1988). Oc- 
tamer motifs are strategically placed in both the heavy- 
and the K light-chain immunoglobulin enhancers (Singh 
et al. 1986; Currie and Roeder 1989; Nelms and Van 
Ness 1990; Pettersson et al. 19901 and in all V-gene pro- 
moters iFalkner and Zachau 1984; Parslow et al. 19841, 
often adjacent to an additional octamer-binding motif, 
the heptamer (Eaton and Calame 1987). 
An important role for Oct-2 in regulating immuno- 
globulin gene activity in B cells has been suggested but 
not proven (Dreyfus et al. 1987; Wirth et al. 1987; Muller 
et al. 1988; Junker et al. 1990; Jenuwein and Grosschedl 
1991). Such a role was proposed partly because oct-2 ex- 
pression is predominantly B lineage specific (Staudt et al. 
1986, 1988; Schlissel et al. 1991a). Also, Oct-2 is pro- 
duced at all stages of the B lineage (Staudt et al. 1986, 
1988; Schlissel et al. 1991al, giving it the ability to in- 
fluence several developmental steps. However, it is not 
known at which developmental stage Oct-2 exerts its 
primary influence. Furthermore, it has not been estab- 
lished whether Oct-2 plays a role in B cells that clearly 
distinguishes it from other regulators of immunoglobu- 
lingene expression that occupy adjacent binding sites or 
from the ubiquitously expressed octamer-binding pro- 
tein, Oct-1. 
The Oct-1 protein functions in cell cycle-specific reg- 
ulation of histone H2B gene expression {LaBella et al. 
19881 and activation of a number of other cellular and 
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viral genes. Although Oct-1 and Oct-2 are products of 
different genes, they have structural similarities in sev- 
eral domains. The two proteins are most highly related 
in their DNA-binding (POU homeo) domains (Herr et al. 
1988), and thus have almost identical DNA-binding 
specificity. Oct-1 and Oct-2 can cooperate in DNA-bind- 
ing (Kemler et al. 1989), but the significance of this in- 
teraction, particularly in B cells where they are both ex- 
pressed, is unknown {see Schaffner 1989; Ruvkun and 
Finney 1991}. From in vitro experiments with octamer- 
containing promoter constructs, it has even been sug- 
gested that Oct-1 and Oct-2 are interchangeable (L Bow- 
itz et al. 1989; Pierani et al. 1990; Kemler et al. 1991}. 
Such experiments argue against the hypothesis that 
Oct-2 plays a unique role in B cells. Clearly, there are 
many unanswered questions regarding the relationship 
of Oct-2 to B-cell-specific gene expression. 
The large ensemble of factors regulating immunoglob- 
ulin gene expression includes both B-cell-restricted and 
ubiquitous proteins (see Staudt and Lenardo 1991). Evi- 
dence for the function of these proteins comes primarily 
from experiments using cultured cells or cell-free sys- 
tems. Although such approaches provide a valuable 
starting point, they cannot fully define the role an indi- 
vidual protein plays during the couroe of B-cell develop- 
ment in vivo. Isolated cells cannot represent the range of 
physiological states encountered in the body, and B-cell 
lines cannot perform many of the differentiation steps 
taken by B cells in vivo. A more definitive approach to 
establishing the function of a gene is through creation of 
a null mutant {Thomas and Capecchi 1987). We have 
used gene targeting in embryonic stem (ES) cells to gen- 
erate ES cell lines that are heterozygous for a mutant 
oct-2 gene. Unexpectedly, homozygous mutant mice de- 
rived from such a cell line die within hours of birth, 
although the cause of death has not been determined. 
B-cell differentiation i these young mutant animals ap- 
pears to proceed normally to the stage of the virgin B cell, 
indicating that Oct-2 is dispensable during the antigen- 
independent phase of development. However, mutant B 
cells have difficulty developing past this tage, and stim- 
ulation of these cells in vitro reveals a severe functional 
defect. This implies that the Oct-2 transcription factor 
plays an essential role late in B-cell differentiation, when 
cells increase immunoglobulin expression i  response to 
external stimuli. 
Resul ts  
Targeting the oct-2 gene 
Oct-2 binds to DNA through a bipartite-binding domain 
(Fig. 1A), comprising POU-specific and POU homeo do- 
mains; both are required for specific high-affinity bind- 
ing to the octamer motif (Sturm and Herr 1988; Verrijzer 
et al. 1990). The oct-2 targeting vector (see Materials and 
methods; Fig. 1B) was designed to introduce a nonsense 
mutation into the middle of the POU-specific domain of 
the protein (Fig. 1A). Any Oct-2 derivative expressed 
from the mutated gene would not be expected to bind to 
DNA, as it would lack the entire carboxy-terminal half 
of the protein, including the homeo box. After transfec- 
tion of D3 ES cells with the targeting vector, G418-re- 
sistant (or G418 and gancyclovir doubly-resistant) clones 
were screened directly by Southern analysis. Clones 
bearing the desired mutation would contain a smaller 
XbaI fragment, by virtue of the XbaI linker carrying the 
nonsense mutation (Fig. 2A}. Overall, -1  in 14 G418- 
resistant clones resulted from a homologous event (Ta- 
ble 11. Several clones, both G418 resistant and doubly 
Figure 1. Oct-2 protein, gene, and targeting vector 
structures. (A) Diagrammatic representation f the 
Oct-2 protein, with functional domains high- 
lighted. The asterisk 1,) marks the position in the 
protein sequence where the nonsense mutation 
would occur in the mutated allele. (B) [Top} The 
structure of the wild-type murine oct-2 gene in the 
region encoding the POU-specific and POU homeo 
domains {shading i dicates corresponding regions 
in the gene and protein). Our unpublished data on 
the organization and sequence of the mouse gene 
agree with those published by Hatzopoulos et al. 
(19901. The targeting vector (bottom] contains the 
two selectable markers hown and an Xba linker 
containing multiple stop codons (Xba STOP) at the 
oct-2 NcoI site. {Probe} The fragment used in 
Southems blots shown i Fig. 2, a StuI-BamHI ge- 
nomic fragment, a and b delineate fragments ex- 
pected upon XbaI digestion of the germ line and 
targeted oct-2 alleles, 4.6 and 3.4 kb, respectively. 
Arrows indicate transcriptional orientation of se- 
lectable marker genes. 
GENES & DEVELOPMENT 571 
 Cold Spring Harbor Laboratory Press on April 24, 2020 - Published by genesdev.cshlp.orgDownloaded from 
Corcoranetal.  
fragment detected by both the oct-2 and neo probes cor- 
responds to the mutant oct-2 allele (Fig. 2B). 
Figure 2. Southern analysis of selected ES cell clones to detect 
homologous recombination atthe oct-2 locus. (A)XbaI-digested 
DNA hybridized with the oct-2 probe in Fig. lB. Potential prod- 
ucts of homologous recombination depend on the position of 
the 5' crossover point with respect to the XbaI/nonsense linker. 
If recombination occurred 5' to the XbaI linker, a 3.4-kb XbaI 
fragment would result. If it occurred 3' to the linker, a 6.4-kb 
XbaI fragment would be generated. Approximately 1 in 20 
clones contained both the XbaI/nonsense linker and neo (and 
thus yielded the 3.4-kb XbaI fragmentl, as the crossover had 
occurred in the 1.8-kb upstream of the XbaI linker mutation 
(see Fig. 1B]. Those clones in which the crossover point fell 
between the XbaI linker and the neo gene were identified by 
virtue of the 6.4-kb XbaI fragment . The same fragment also 
hybridized to a neo probe (data not shown). This latter set of 
clones was excluded, as they had not incorporated the desired 
oct-2 mutation. (B) Southern analysis of KpnI-digested DNA 
from tails of wild-type, heterozygous, and oct-2 mutant mice 
probed with the oct-2 IFig. 1B) or neo probes. The asterisk (*) 
marks the position of the mutated allele. 
resistant, were chosen for injection into C57BL/6 blas- 
tocysts. Mice derived from one clone transmitted the 
oct-2 mutation to their progeny; the mutation was car- 
fled by one-half of the offspring (38 - / + and 41 + / + of 
those analyzed). These F1 animals were healthy and sub- 
sequently proved to be fertile. Mice were subjected to 
further Southern a alysis using KpnI, to ensure that they 
carried a mutated oct-2 allele with the correct structure, 
and only one copy of the neo gene. As KpnI sites flank 
the neo insertion in the mutant allele, the larger KpnI 
Oct-2 deficiency causes neonatal death 
When animals heterozygous for the oct-2 mutation were 
mated, genotypic analysis of all progeny in the first few 
litters revealed a ratio of oct-2 genotypes close to the 
expected 1 : 2 : 1 (Table 2), indicating that the oct-2 mu- 
tation was inherited in a Mendelian fashion and that 
most animals survived to birth, regardless of genotype. 
However, within a few hours of birth, some animals be- 
came lethargic, cyanosed and ehydrated, and finally 
died. Genotyping confirmed that the dying pups were 
oct-2 nullizygotes (Table 2). No oct-2- / - mouse has sur- 
vived for more than a few hours. Live-born oct -2 - / -  an- 
imals were distinguishable from their littermates only 
by the absence of milk in the stomach, because they do 
not suckle. However, starvation is unlikely to be the 
cause of death at such an early time, because normal 
mice delivered by Caesarian section in our animal facil- 
ity have survived for 24 hr or more without feeding. His- 
tologic examination did not reveal any indication of in- 
fection or of anatomical abnormality: The lungs were 
pink and inflated; the heart, spleen, liver and thymus 
were normal in size, color, and histologic appearance; 
and the kidneys were functioning, as indicated by full 
bladders. Because oct-2 is expressed in the developing 
nervous ystem (Hatzopoulos et al. 1990; Stoykova et al. 
1992), we paid particular attention to the brain and al- 
though we cannot rule out a physiological lesion, no 
structural defect was evident. 
That neonatal lethality is the consequence of the oct-2 
mutation, and not some other undetected mutation, is 
supported both by the presence of a single copy of the 
targeting vector, integrated correctly at the oct-2 locus 
(Fig. 2), and by the fact that lethality and homozygosity 
for the oct-2 mutation have cosegregated without excep- 
tion for more than six generations of breeding of many 
independent animals. Although the neonatal death of 
Oct-2-deficient animals remains to be explained, it at- 
tests to a late developmental role for Oct-2 outside of the 
immune system. 
Early B-cell development is normal in oct-2- / - mice 
Immunoglobulin genes are rearranged and tran- 
scribed Despite the neonatal ethality accompanying 
oct -2 - / -  deficiency, a significant part of the B-cell de- 
velopmental pathway was accessible for analysis. During 
mid- to late gestation, the liver is a major site of he- 
matopoiesis (Owen et al 1977). The immunoglobulin 
genes become transcriptionally active in fetal iver B-cell 
precursors before the onset of rearrangement and are 
then rearranged in a characteristic temporal sequence 
into functional antibody-coding units {see Alt et al. 
1987; Schatz et al. 1992). These gene rearrangements are 
specific to lymphocytes, and the type of rearrangement 
present reflects the state of differentiation ofa given cell. 
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Tab le  1. Frequency of homologous recombinants 
Frequency 
Number of 
Exper iment  G418 a G418 + GANC R homologous recombinants C-618 g G418 + GANC R 
1 - -  130 26 [18 + 81 a - -  1 in 5 
2 95 -- 5{1 + 4} b l in19 -- 
Colonies creened 
"Eighteen colonies had the desired ouble mutation, and 8 contained only the neo gene. 
bOne colony had the desired ouble mutation, and 4 contained only the neo gene (see text). 
If Oct-2 were a regulator of germ-line immunoglobul in 
gene transcription through action at promoter or en- 
hancer octamer sites and transcription were a prerequi- 
site for gene rearrangement, as has been proposed (Alt et 
al. 1987), then mutant animals might show a defect in 
one or more of the rearrangement s eps, potentially 
blocking differentiation. Immunoglobul in gene rear- 
rangements in fetal liver cells were measured using a 
sensitive polymerase chain reaction (PCR) assay (Schlis- 
sel et al. 1991al. The assay detects the products of im- 
munoglobulin gene rearrangements, with the size of 
each product reflecting the ]H element used in the rear- 
rangement. The results in Figure 3 show that B-cell pre- 
cursors of oct-2 mutant mice were able to perform D-!  
and V-DI  rearrangements of the heavy-chain and V-!  
rearrangements at the K locus as well as their normal 
littermates, and therefore indicate that fetal liver pre-B 
cells in mutant animals can progress normally through 
these early differentiation steps. The abundance of rear- 
ranged products varied somewhat among the animals 
but did not correlate closely with oct-2 genotype. There- 
fore, Oct-2 binding is not a prerequisite for immunoglob- 
ulin gene rearrangement. 
Fetal liver pre-B cells are susceptible to transformation 
by Abelson murine leukemia virus {A-MuLV} {Rosenberg 
et al. 19751. A-MuLV-transformed cell lines could be de- 
rived from day-16 fetal liver of both mutant and normal 
animals with similar efficiency [data not shown), indi- 
cating that A-MuLV targets occur in oct-2-  / - animals at 
approximately normal frequency. These cell lines were 
used as a source of pure B-lineage cells to confirm that 
the oct-2 mutation described in FigurelB was a true null  
mutation. Northern blot analysis was not sensitive 
enough to accurately measure oct-2 mRNA levels in 
these early ceils {data not shown}. Other more sensitive 
methods of RNA detection, such as RNase protection or 
PCR, would only reveal transcription of a region of the 
gene and not whether stable, full-length RNA was 
present. Furthermore, the influence of the introduced 
phosphoglycerokinase {PGKI promoter and polyadenyla- 
tion signals on oct-2 transcription might make interpre- 
tation difficult. Therefore, Oct-2 protein levels were ex- 
amined using a sensitive Westem blotting assay. Nu- 
clear proteins extracted from A-MuLV-transformed cells 
from wild-type and mutant animals were compared with 
similarly prepared (Schreiber et al. 1989) proteins from 
the mouse B-cell line, WEHI-231 (Gutman et al. 1981), 
using an anti-Oct-2 antiserum. This serum was raised 
against full-length, bacterially synthesized Oct-2 protein 
(Wirth et al. 1991). Whereas the cross-reactive Oct-1 pro- 
tein was visible in extracts from both normal and mu- 
tant cells, Oct-2 was not detected in the mutant  ceils 
although it was readily detected in normal cells (Fig. 41. 
Furthermore, the antiserum did not detect any smaller 
Tab le  2. Genotypes of F2 animals 
All animals a Neonata l  
Genotype (% } deaths Survivors 
- / -  22 {20} b 16 0 
- / + 63 [58} 1 42 
+/+ 24 122} 0 18 
a{F2] Heterozygous females x heterozygous males, n = 109. 
bCannibalism of dead or dying pups by the mother educed this 
frequency slightly. 
Figure 3. Immunoglobulin gene rearrangements in day 16 fetal 
liver cells. The reactions were performed and analyzed exactly 
as described previously {Schlissel and Baltimore 1989~ Schlissel 
et al. 1991a} The oct-2 genotype of each fetus is indicated. (C) 
Control reactions lacking DNA~ (Spl] adult spleen control. 
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Figure 4. Oct-2 protein expression in mutant and control pre-B 
cell lines. Western blot of nuclear proteins from the mouse 
B-cell line WEHI-231 and from pools of A-MuLV-transformed 
fetal liver from Oct-2-deficient and wild-type animals. 
Coomassie staining indicated that approximately one-fifth as 
much protein was present in the WEHI-231 lane, compared with 
the A-MuLV lines (data not shownl. The blot was reacted with 
rabbit serum (1 : 1000) raised against nearly full-length, bacte- 
rially synthesized Oct-2 (Wirth et al. 1991) and developed by 
enhanced chemiluminescence (ECL,Amersham}. Both Oct-1 
and Oct-2 are recognized by this antiserum. 
Oct-2 derivatives in mutant cells, indicating that no sta- 
ble protein is produced from the mutated allele. 
To examine the effect of loss of Oct-2 on gene expres- 
sion, transcription rates of genes characteristically ex- 
pressed in pre-B cells were measured. These included 
genes for the immunoglobulin heavy and K light-chains, 
for VpreB and ~5, the surrogate light-chains of pre-B 
cells, for the recombination-activating genes, RAG-1 and 
RAG-2, and for the immunoglobulin-associated chains, 
mb-1 and B29. Within this group are genes like B29 and 
the immunoglobulin genes, thought o be dependent on 
Oct-2 for their expression (Hermanson et al. 1989). Nu- 
clear run-on assays measured transcription rates in 
cloned A-MuLV-transformed lines from control and mu- 
tant mice and also examined the effect of Escherichia 
coil lipopolysaccharide (LPS) treatment on the rate of 
transcription. Six individual pre-B clones (4 mutant and 
2 wild-type) were examined, and typical results are 
shown in Figure 5. The genotypes of the mutant and 
wild-type cells were confirmed by Southern blotting to 
rule out contamination by wild-type cells {data not 
shown). Transcription rates of the genes examined were 
generally unaltered in the oct-2 null clones. Clearly, 
Oct-2 is not required for the expression of immunoglob- 
ulin genes, or the other B-cell-specific genes tested, at 
the pre-B-cell stage of development. 
Fetal pre-B- and B-cell numbers and surface phenotypes 
are not perturbed Maturing B-lineage cells in normal 
and mutant animals were quantitated. First, surface 
markers on cells from day 16/17 fetal liver were ana- 
lyzed. The B220 molecule is present on very early B-cell 
precursors and persists through most of B-cell differen- 
tiation (Coffman and Weissman 1981). The ~ chain ap- 
pears later on the surface of B cells after productive re- 
arrangement of a heavy-chain gene and association with 
a light chain. The results were the same for two inde- 
pendent litters analyzed; oct-2 nullizygotes could not be 
distinguished from their littermates. All animals had 
similar numbers of B220 + ~+ (0.1-0.6%} and B220 + ~- 
cells (1-3%; Fig. 6A and data not shown). Thus, flow 
cytometric analysis indicated that pre-B- and B-cell num- 
bers were not affected by the mutation. 
The number of clonable pre-B cells in normal and mu- 
tant animals was then compared. The cells were enu- 
merated through their ability to proliferate when cul- 
tured on a feeder layer of IL-7-producing cells (Cumano 
et al. 1990; Rolink et al. 1991a; see Materials and meth- 
ods). Limiting numbers of live cells from newborn liver 
and spleen were plated on 3T3 cells stably expressing 
IL-7 (Rolink et al. 1991a}. After 10 days, proliferation of 
cells resembling lymphocytes was scored by microscopic 
examination. Analysis of surface markers on cells at the 
end of the incubation period indicated that >98% of 
cells were B220 + and PB76 + (data not shown), as ex- 
pected for pre-B cells (Strasser 1988; see Rolink and 
Melchers 19911. Regression analysis of the proliferation 
data yielded the frequencies hown in Figure 6B. Al- 
though some variation in early pre-B-cell frequencies 
was observed among the individuals, there was no sig- 
nificant difference between mutant and heterozygous or
Figure 5. Transcriptional ctivity of genes in mutant and nor- 
mal pre-B-cell ines. A-MuLV-transformed pre-B cells from an 
oct-2 null animal {1227/4} and a control Iittermate (1220/3) 
were analyzed by nuclear run-on assay. Transcription rates of 
B-lineage-specific genes were measured in the absence (-) and 
presence { + ) of LPS. pGEM-3 is a vector control. 
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of B-cell production, whereas the spleen is the site to 
which preformed B cells migrate for further development 
in response to antigenic and other signals. Because oct-2 
nullizygotes died at birth, the most mature B cells avail- 
able were those in the neonatal liver and spleen. These 
tissues were taken from newborn mice shortly after de- 
livery, when both mutant and control animals were vi- 
able and quite mobile. Flow cytometric analysis was per- 
formed to determine the proportion of B cells (B220 +, 
~+) present. Several additional strategies were included 
to ensure that the cells detected represented the true 
B-cell population in the organ examined (Materials and 
methods), because previous work had demonstrated that 
these cells represent a small minority of cells in such 
young animals (Nossal and Pike 1973). 
B-cell numbers were compared for 22 animals from 
four litters, including 9 homozygous mutants, and rep- 
resentative data are shown in Figure 7. The flow cyto- 
metric data in Figure 7 show only the B220 and ~ pro- 
files; the I~ + cells from both mutant and control livers 
Figure 6. Enumeration of early B cells in fetal and newborn 
tissues. (A) B cells in fetal iver of mutants and controls. Values 
are percentages of B220+, W + cells in day 16 fetal liver. Each 
value is from an individual fetusl two litters were analyzed. 
Genotypes of controls are indicated. [B) Frequency of clonable 
pre-B cells from control and mutant mice. Values are frequen- 
cies of clonable pre-B cells/100 unfractionated newborn liver or 
spleen cells. Each value represents an individual animal, and all 
are littermates. Genotypes of control animals are indicated. 
wild-type animals. Both liver and spleen showed a mean 
pre-B-cell frequency of ~ 1 in 170. Proliferative capacity 
of pre-B ceils, as judged by the size of visible colonies, 
seemed unaffected by the oct-2 mutation. The conclu- 
sion from this eries of experiments i that Oct-2 is not 
required for the generation or proliferation of B-cell pre- 
cursors or for the productive rearrangement or expres- 
sion of immunoglobul in genes in developing B cells. 
Mature B-cell numbers are marginally depressed 
in oct-2-deficient eonates 
From mid-gestation to birth, the liver is the primary site 
Figure 7. B220 § ~+ B ceils in newbom liver and spleen. The 
percentage ofB220 +, FL + cells is shown in each dot plot, along 
with the genotype of the animal. The flow cytometry plots are 
only shown for spleen, but the summary (bottom right) includes 
data from liver. Each value in the summary graph represents a 
separate animal. 
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were also predominantly K+, BP-1 +, PB76 +, IgD-, 
CD23 -, and class II- (data not shown). This surface phe- 
notype classifies these cells as virgin or immature 
(IgM +, D- t  B cells {see Rolink and Melchers 1991). By 
the time of birth, the numbers of B cells had risen sig- 
nificantly from their day 16/17 levels (in Fig. 6A). 
Whereas total nucleated cell numbers in neonatal liver 
and spleen were found to be equivalent for mutant and 
control animals (data not shown), hepatic B cells were, 
on average, slightly more abundant in +/+ animals 
than in mutants, with heterozygotes having an interme- 
diate level. There was, however, considerable overlap in 
the range of B-cell numbers measured in liver for mice of 
each genotype (Fig. 7, bottoml, and some litters showed 
little difference between mutants and controls. In con- 
trast, there was a clear effect on the proportion of B cells 
in newborn spleen; wild-type animals averaged four 
times more IgM + cells than mutants. This first evidence 
of the phenotypir consequence of Oct-2 deficiency im- 
plies a differentiation or proliferation defect in the virgin 
B cell. The difference between liver and spleen may re- 
flect the primary and secondary nature, respectively, of 
these two lymphoid organs. 
A closer look at the B-lineage cells in mutant and nor- 
mal spleens revealed not only that IgM + cells were more 
abundant in wild-type animals, but the ratio of pre-B to 
B cells was slightly altered by the oct-2 mutation. The 
BP-1 molecule, present on pre-B and immature B cells 
(Cooper et al. 19861, is lost with further B-cell differen- 
tiation {Rolink and Melchers 1991). In spleens from con- 
trol animals, mature B cells (~+, BP-1-) predominated 
over pre-B cells {Ix-, BP-1 +) (Fig. 8). However, in oct- 
2- / -  animals, the balance was skewed toward the less 
mature {~-, BP-1 +} cells, indicating either a block or a 
Figure 8. Pre-B and B cells in newborn spleen. The relative 
proportions of pre-B (BP-1 +, ~-; solid bars] and B (BP-I-, ~§ 
strippled barst cells in spleens of individuals from two indepen- 
dent litters are shown, with corresponding oct-2 genotype. 
delay in the differentiation of mutant B cells at this late 
stage. This may account, in part, for the depression of 
IgM + B-cell numbers in spleens of oct-2 nullizygotes. 
The distribution of PB-76, CD23, and class II markers on 
IgM + cells was not affected by the mutation (data not 
shown), 
Oct-2 mutat ion disrupts activation and ant ibody 
secretion by mature B cells 
When B cells are stimulated in vitro by the mitogen LPS, 
in the presence of 3T3 filler cells and optimal concen- 
trations of IL-2, IL-4, and IL-5, clones of antibody-form- 
ing cells are induced that first secrete IgM and then later 
frequently switch to secretion of IgG1 and/or IgE 
{McHeyzer-Williams 1989). Cells from lymphoid organs 
of newbom oct.2 - / -  animals and normal littermates 
were stimulated under such culture conditions (Materi- 
als and methods) to measure their capacity to differenti- 
ate to activated IgM-secreting cells and to switch to IgG 1 
secretion. A dilution series of viable cells from individ- 
ual livers and spleens was plated and at the end of the 7- 
to 8-day culture period microscopic inspection indicated 
that all samples had a similar proportion of wells con- 
taining typical clusters of lymphocytes. IgM and IgG1 
levels were measured in all culture supematants at the 
end of the culture period, and the frequency of antibody- 
forming clones (AFC) was determined. A comparison of 
these frequencies (Fig. 9A, B) revealed adramatic effect of 
Oct-2 deficiency; the livers of mutant animals contained 
20-fold fewer cells capable of secreting antibody of either 
the IgM or IgG1 isotype, compared with homozygous 
wild-type animals. In the spleen~ the average deficit was 
100-fold for IgG1 and nearly 200-fold for IgM producers, 
respectively. Once again, heterozygous animals tended 
to have intermediate values. Furthermore, the clones 
from mutant animals that could secrete immunoglobu- 
lin did so to a much lesser extent. Figure 9C summarizes 
data obtained by measuring the amount of immunoglob- 
ulin secreted by individual clones (Materials and meth- 
odsl. Liver-derived clones from oct-2 mutants ecreted, 
on average, 16- and 10-fold less IgM and IgG1, respec- 
tively, than wild type, whereas B cells from mutant 
spleen were 55- and 70-fold less productive (for IgM and 
IgG1, respectively) than + / + controls. Immunoglobulin 
production by heterozygotes fell between the two ex- 
tremes. If the antibody-secreting capacity of he whole 
organ is considered, then the compound effects of the 
paucity of antibody-secreting cells in mutant animals 
and the poor performance of those few functional cells 
present would translate into a significant immunodefi- 
ciency. These results predict hat de novo immunoglob- 
ulin production by the two major B-lymphoid organs of 
the oct-2-  / - newborn would be severely depressed (200- 
to 320-fold for liver and 7000- to 10,000-fold for the 
spleen). 
Discuss ion  
Oct-2-deficient mice provide the first opportunity to de- 
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Figure 9. Immunoglobulin secretion by LPS-stimulated B 
cells. {A) Frequency of IgM-secreting clones induced by LPS 
treatment of unfractionated cells from neonatal iver and 
spleen. For liver, six mutant, five heterozygous, and five wild- 
type animals were analyzed. The spleens from a subset of these 
animals were also analyzed (5 - / - ,  3 - /+ ,  and 4 +/+.  (B) 
Frequency of IgG1 secretion by the same cells analyzed in A 
above. (C) The amount of antibody secreted by antibody-secret- 
ing clones, pooled according to oct-2 genotype {Materials and 
methods]. {Solid bar) Liver; {open barl spleen. The large error 
bars {standard deviation I reflect the small number of pooled 
samples and the fact that immunoglobulin secretion varied dra- 
matically among pooh. However, the oct-2- / - cells always had 
the lowest average l vel of antibody production. 
termine the role of Oct-2 in the development of the B 
cell. Previous tudies with cell lines have failed to estab- 
lish a definitive role for Oct-2 in immunoglobulin gene 
Oct-2 required late in B-cell differentiation 
expression. On the basis of such experiments, it could be 
argued that Oct-2 is required for the expression of any 
immunoglobulin gene or that it makes only a modest 
contribution to that expression. Furthermore, the early 
notion of a specialized function for Oct-2 in B cells had 
been challenged by evidence for functional overlap be- 
tween Oct-1 and Oct-2. The experiments reported here 
show that although the oct-2 gene is expressed early in 
the B-cell lineage, it has no recognizable function in the 
early fetal B lymphocyte but is clearly needed for the 
later functional development of the B cell. The oct-2 
gene product is also critical for viability of the newborn 
mouse, but the organ system or cell type in which it is 
required could not be identified. 
Oct-2 is dispensable during early B.cell development 
Despite the fact that oct-2 is expressed at very early 
stages of the B-cell lineage {Schlissel et al. 1991a}, this 
work indicates that the protein is not required for the 
early transcription of immunoglobulin genes (Fig. 5) or 
for immunoglobulin gene rearrangements in pre-B cells 
(Fig. 3). Furthermore, A.L. Feldhaus, C.A. King, K.L. 
Arvin, and H. Singh {pets. comm.I have largely elimi- 
nated expression of the oct-2 gene by homologous re- 
combination in WEHI-231 B-lymphoma ceils, and have 
observed no diminution of immunoglobulin gene tran- 
scription in such cells, in agreement with our observa- 
tion that lymphoid cells can mature to the B-cell stage 
without Oct-2. Therefore, other transcriptional activa- 
tors that act at sites in the immunoglobulin promoters 
and enhancers, such as the helix-loop-helix proteins 
that bind to the so-called E boxes {Eaton and Calame 
1987) or the factors that bind to the ~B or ~r boxes (Liber- 
mann et al. 1990; Nelsen et al. 1990), must provide a 
level of transcription that is adequate to achieve early 
steps of B-cell differentiation. Overexpression f the E47 
protein in T cells activates germ-line transcription and 
D-to-J rearrangement of the immunoglobulin heavy 
chain [Schlissel et al. 1991b 1. Another obvious candidate 
for a factor that might complement an Oct-2 deficiency 
in early B cells is the ubiquitously expressed Oct-1. In 
developing B cells that lack Oct-2, Oct-1 might partici- 
pate in immunoglobulin expression through action at 
the octamer motif, as has been demonstrated in vitro 
(Pierani et al. 1990). However, the work described here 
shows clearly that Oct-1 cannot adequately complement 
an Oct-2 deficiency in mature B cells nor in the system 
that depends on Oct-2 for animal survival, indicating 
unique biochemical roles for Oct-2. 
Maturation defect in oct-2-deficient B cells 
The first evidence of a B-cell developmental defect in 
Oct-2-deficient mice was a deficit in splenic B cells at 
the time of birth, due in part to the slightly impaired 
maturation capacity of these cells. Because the animals 
died postnatally, other events in B-cell differentiation 
had to be followed in vitro. These studies uncovered a
significant developmental arrest. Although LPS could in- 
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duce normal B cells to develop into immunoglobulin- 
secreting cells, the oct-2 - / - cells responded poorly. Few 
were induced to secrete immunoglobulin, and these se- 
creted very little. Surprisingly, even heterozygotes 
showed a deficiency in development to immunoglobulin 
secretors, implying that Oct-2 is a limiting factor in this 
maturation step. In the few antibody-producing clones 
derived from mutant cells, the switch to IgG1 synthesis 
occurred with normal efficiency, despite the presence of 
several potential Oct-2-binding sites in the 71 switch 
region (Schultz et al. 1991}. 
LPS induces a pleiotropic response in B-lineage cells, 
involving functional activation, proliferation, and differ- 
entiation (e.g., see Anderson et al. 1977). Whereas anti- 
body levels in culture supernatants could readily be mea- 
sured in the in vitro activation experiment, he small 
numbers of cells involved and their failure to survive the 
assay have not allowed us to characterize the cells after 
LPS treatment. It therefore remains a possibility that 
Oct-2 affects the LPS-induced proliferation of B cells, 
rather than the rate of antibody secretion, and detailed 
frequency analysis of clonal proliferation is under study. 
It should be noted that whereas blastogenesis, oJ onal pro- 
liferation, and differentiation to antibody-secreting sta- 
tus are usually coupled events in B-cell physiology, little 
is known about the regulation of continued ivision ver- 
sus terminal differentiation. There are even some in- 
stances where B cells can be induced to secrete antibody 
without prior cell division (Melchers et al. 1980). 
LPS treatment induces dramatic hanges in immuno- 
globulin gene expression (Yancopoulos and Alt 1985) and 
increases oct-2 transcription (Staudt et al. 1986, 1988; 
Miller et al. 1991). LPS may therefore influence immu- 
noglobulin gene activity, in part, through induction of 
oct-2, and oct -2 - / -  B cells may fail to secrete immuno- 
globulin in response to LPS because they cannot up-reg- 
ulate Oct-2 production. In this scenario, binding sites in 
the V-gene promoter and the 3' IgH enhancer might be 
the critical regulatory elements at which Oct-2 would 
act, as they have been shown to contribute strongly to 
immunoglobulin gene expression in mature B cells in 
vivo (Jenuwein and Grosschedl 1991) and plasma cells in 
vitro (Dariavach et al. 1991). 
Although the defect in immunoglobulin secretion may 
be the primary lesion in oct -2 - / -  B cells, maturation 
involves the action of many genes, any one of which may 
be affected by the mutation. For example, Oct-2 may, in 
an undefined way, participate in a late maturation step 
that makes an IgM + B cell LPS responsive. Alterna- 
tively, the protein may influence signal transduction at 
the B-ceil surface, through levels of the B29 molecule. 
B29 is an immunoglobulin-associated protein, analogous 
to a component of the GD3 signal-transducing complex 
of the T-cell receptor (Cambier and Campbell 1990), 
which is phosphorylated in response to surface immu- 
noglobulin cross-linking(Gold etal. 1991). Transcription 
of the B29 gene is potentially regulated by Oct-2, through 
a perfect octamer motif in the B29 gene promoter (Her- 
manson et aI. 1989). 
Finally, it is important o remember, when consider- 
ing the general role ofOct-2 in B-cell differentiation, that 
the B-cell populations of newborn mice and adults differ. 
Ly-1 B ceils, which arise early in development, are re- 
garded as a distinct lineage, with surface markers, anti- 
body repertoires, and regeneration characteristics that 
distinguish them from the conventional B cells that pre- 
dominate in the adult (Hardy and Hayakawa 1986; 
Herzenberg et al. 1986). The important effects of Oct-2 
deficiency on B-cell maturation in newborns described 
here may differ from effects on adult B cells. 
Effects on other hematopo ie t i c  cell l ineages 
It has been reported that B cell precursors can give rise to 
B cells or myeloid cells, depending on the lymphokines 
present (Cumano et al. 19921, and that Oct-2 is expressed 
in some myeloid cell lines (Staudt et al. 1988; Cockerill 
and Klinken 1990). Nevertheless, myeloid development 
was not disturbed in oct-2 mutant animals; the number 
and morphology of colonies observed in agar culture of 
day 13 fetal liver were normal, and Oct-2 null macro- 
phages generated in the presence of M-CSF were highly 
phagocytic (L.C. Metcalf and D. Metcalf, unpubl.). 
Oct-2 is also expressed in some T-cell lines (Staudt et 
al. 1988; Cockerill and Klinken 1990; Schlissel et al. 
1991a), and in primary T cells, where it is induced by 
antigenic stimulation (Kang et aI. 1992). In preliminary 
experiments, newborn thymocytes from Oct-2-deficient 
animals appeared in normal numbers and with normal 
surface phenotypes. However, very few mature cells are 
present in the thymus at this age, so the behavior of 
mature T cells could not be assessed. 
This study of B-cell development in the absence of a 
functional oct-2 gene provides information about Oct-2 
function at late stages of B-cell development and there- 
fore distinguishes the actions of Oct-2 from the other 
transcription factors influencing immunoglobulin gene 
expression. By removing Oct-2 from consideration, es- 
sential elements controlling immunoglobulin gene ex- 
pression in immature B cells should now be defined 
more easily. Oct-2-deficient B cells may also help to de- 
fine the molecular events that occur when virgin B cells 
respond to environmental signals and differentiate o im- 
munoglobulin-secreting cells. Finally, SCID (severe 
combined immunodeficiency) mice, which fail to make 
their own B or T lymphocytes, can be repopulated with 
Oct-2-deficient B cells. The phenotypically mature B 
cells in such repopulated animals display similar func- 
tional defects to their neonatal counterparts, both in 
vivo and upon activation in vitro. These animals may 
represent a new model of immunodeficiency, with the 
oct-2 mutation imparting akind of nonspecific anergy to 
mature B cells, in contrast to the early defects that derail 
B-cell development in mice lacking functional ~5, ~M, 
RAG-l, or RAG-2 genes (Kitamura et al. 1991, 1992; Mo- 
mbaerts et al. 1992; Shinkai et al. 1992). 
Materials and methods 
oct-2 targeting vector 
The mouse oct-2 gene was isolated from a genomir l brary from 
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T-cell hybridoma 1.9.2 [a hybrid between cells from B10.A and 
AKR inbred mouse strains {Winoto et al. 1985), using a human 
oct-2 cDNA probe (Staudt et al. 1988; Clerc et al. 19881. In 
constructing the substrate for gene targeting, three changes 
were made to the oct-2 gene {Fig. 1C). All were insertions; no 
oct-2 sequences were replaced or deleted during the construc- 
tion. The first was a nonsense mutation, in the form of an XbaI 
linker with stop codons in all frames, introduced into the NcoI 
site in the POU-specific domain. A cassette containing the n o 
gene [Mansour et al. 1988) was then inserted at a site just down- 
stream of the homeo domain (Fig. 1C). As the oct-2 gene is not 
appreciably transcribed in ES cells (RNase protection results not 
shownl, we supplied the neo gene with the strong PGK pro- 
moter and polyadenytation signal (Tybulewicz et al. 1991). A 
thymidine kinase cassette was inserted at the 5' end of the 
targeting substrate for enrichment by selection against random 
integration of DNA (Mansour et al. 1988). The resulting target- 
ing vectors had 2.9 kb of oct-2 sequences, 5' of the neo insertion, 
and 3.0 kb of homology, 3'. The distance between the XbaI 
linker and the neo gene was 1.1 kb. 
Transfection, selection, and screening for 
homologous recombinants 
D3 ES cells (Gossler et al. 1986) were propagated on 7-irradiated 
(20 Gy) STO neo fibroblasts as described (Zijlstra et al. 1989). ES 
cells (8 x 106) were electroporated (400 V, 25 ~F) in the presence 
of 20 jzg of linearized targeting vector, and G418 (300 fzg/ml), 
with or without gancyclovir [2 ~M) selection was initiated 24- 
48 hr later. Individual clones were picked after 6-8 days of se- 
lection, and expanded, and separate aliquots were frozen and 
were processed for Southern analysis. 
Nuclear run-on assay 
Nuclear run-on assays were performed essentially as described 
(Linial et al. 1985; Spanopoulou et al. 1988). Briefly, cells were 
grown to a density of 5 x 105/ml in duplicate flasks. To one 
flask LPS was added to a final concentration of 10 ~g/ml. Cells 
were harvested 24 hr later. Nuclei were isolated from 1-2 x l0 s 
cells by lysing cells in buffer containing the nonionic detergent 
NP-40 and immediately frozen in liquid nitrogen. Thawed nu- 
clei were incubated in the presence of [~-a~P]UTP, and RNA was 
purified. Equal amounts of radiolabeled RNA were hybridized 
to nitrocellulose filters to which various cDNAs had been blot- 
ted. 
In vitro culture of pre-B cells 
A dilution series of unfractionated, viable cells from newborn 
livers and spleens {from mutant, heterozygous or wild-type lit- 
termates) was plated on 96-wetl plates, in the presence of 
2 x 104 3T3 cells stably expressing IL-7 (Rolink et al. 1991a}. 
Thirty-two wells were plated for each dilution (1000, 100, and 
10 cells]. Cells were cultured in RPMI-1640 + 10% fetal calf 
serum supplemented with 50 ~M 2-mercaptoethanol. After 10 
days, wells were examined microscopically and scored for the 
presence of proliferating lymphoctyes. 
Activation of mature B cells 
A threefold ilution series of 5000-150 viable c lls from new- 
born liver or spleen was plated on 96-well dishes {24 wells for 
each dilution) and cultured for 7-8 days in the presence of LPS, 
IL-2, IL-4, and IL-5, and 3T3 cells (5000 cells per well) as de- 
scribed [McHeyzer-Williams 1989). The lymphokines IL-2, IL-4, 
Oct-2 required late in B-cell differentiation 
and IL-5, act as B-cell growth and differentiation factors, and 
IL-4 can promote maturation and heavy-chain class switching 
to the 71 gene (Arai et al. 1990). 3T3 feeder cells provide addi- 
tional support, potentially via IL-6 and steel factor (see Arai et 
al. 1990; Rolink et al. 1991b]. At the end of this period, 25 ~1 of 
each culture supematant was assayed for the presence of IgM or 
IgG1 by standard ELISA (Karvelas and Nossal 1992 I. Clones 
with an OD. > 0.1 were scored as positive. Levels of antibody 
production by individual clones were estimated by measuring 
antibody titers in pools of supernatants from positive clones of 
each oct-2 genotype, from wells that were statistically unlikely 
to contain more than one clone of antibody-secreting cells. 
Flow cytometry 
Monoclonal antibodies RA3-6B2 [anti-CD45R(B220), R-phyco- 
erythrin conjugated], and R6-60.2 {anti-IgM, fluorescein conju- 
gated) were obtained from Pharmingen, and G10 (anti-BP-1, bi- 
otin conjugated) was a kind gift from Dr. Andeas Strasser {The 
Walter and Eliza Hall Institute, Melbourne, Australia). Cyto- 
metric analysis was performed with a FACScan {Becton Dick- 
inson). Controls and parallel experiments were performed to 
ensure the specificity of labeling B-lineage cells, rather than 
cells capable of the passive acquisition of immunoglobulin. The 
controls included incorporation of unlabeled anti-Fc~/receptor 
monoclonal antibody 2.4G2 in staining steps and staining of 
equivalent samples with irrelevant, but species- and isotype- 
matched monoclonal antibodies. Finally, cells stained with 
FITC-labeled sheep antimouse antibody were incubated at 37~ 
for 30 rain and examined by fluorescence microscopy. The 
stained cells had "capped" the fluorescent antibody, a behavior 
characteristic of B cells. The proportion of labeled, capped cells 
agreed well with the flow cytometric data (Fig. 7) on the same 
cell suspensions. 
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for later B-cell maturation and for postnatal survival.
Oct-2, although not required for early B-cell development, is critical
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